DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Gilmore A. et al
Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.
Am J Hematol 2011;
86 (011) 958-61.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.